← FDA DRUG APPROVALS

FDA ANDA · ANDA089649

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE

Sponsor: HOSPIRA

APPLICATION
ANDA089649
TYPE
ANDA
ORIGINAL APPROVAL
1988-06-21
LATEST ACTION
2002-01-02
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINEDiscontinued
EPINEPHRINE 0.005MG/ML, LIDOCAINE HYDROCHLORIDE 1% · INJECTABLE · INJECTION

Approval history

2002-01-02Labeling · Supplement 4AP
1990-11-09Labeling · Supplement 3AP
1990-03-21Labeling · Supplement 2AP
1989-07-06Manufacturing (CMC) · Supplement 1AP
1988-06-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →